TABLE 2.
Jak2 Chromosomal Translocations
| TRANSLOCATION | FUSION PARTNER | DISEASE | REFERENCE |
|---|---|---|---|
| t(9;12)(p24;p13) | TEL-Jak2 | T-ALL, precursor B-ALL, atypical CML, MDS | [52,53,66] |
| t(9;22)(p24;q11.2), t(9;22)(p24;q11) | BCR-Jak2 | atypical CML, AML | [54,55] |
| t(8;9)(p22;p24) | PCM1-Jak2 | atypical CML, precursor B-ALL, CEL, AML, T-cell lymphoma, PMF, MDS/MPN | [56–59] |
| del(9)(p13:p24) | PAX5b | ALL | [60–61] |
| t(5;9)(p14.1;p24.1) | SSBP2 | precursor B-ALL | [64] |
| t(4;9)(q21;p24) | SEC31A-Jak2 | classical Hodgkin Lymphoma (cHL) | [65] |
| t(9;12)(p24;q13) | NFE2c | MDS | [66] |
| add (9) (p24) and del (21)(q11.2) | AML1 (RUNX1)c | MDS | [66] |
| t(3;9)(q21;p24) | RPN1 c | CIMF | [67] |
| t(9;22)(p24;q11.2) | Unknown | B-ALL | [68] |
| t(2;9)(p21;p24) | Unknown | PMF | [69] |
| t(8;9)(q22;p24) | Unknown | PMF | [69] |
| t(9;17)(p24;q23) | Unknown | PV | [69] |
| t(4;9)(q25;p24) | Unknown | PMF | [69] |
| t(8;9)(q13;p24) | Unknown | DLBCL | [69] |
Abbreviations: AML1 - acute myeloid leukemia 1, BCR - B-cell receptor, CML - chronic myeloid leukemia, CEL - chronic eosinophilic leukemia, cHL - classic hodgkin’s lymphoma, CIMF - chronic idiopathic myelofibrosis, DLBCL - diffuse large B-cell lymphoma, ETV6 - Ets variant gene 6, NFE2 - nuclear factor erythroid-derived 2, PAX5 - paired box gene 5, PCM1 - Human autoantigen pericentriolar material 1, PMF - primary myelofibrosis, PV - polycythemia vera, RPN1 - ribophorin 1, SSBP2 - single stranded DNA binding protein 2, T-ALL - T cell ALL.
PAX5-Jak2 is not constitutively active.
Not fully characterized